Moneycontrol
HomeNewscoronavirusCOVID-19 update | Kerala reports 14,373 new cases, 142 deaths in past 24 hours

COVID-19 update | Kerala reports 14,373 new cases, 142 deaths in past 24 hours

As many as 10,751 persons have been cured of the infection, taking the total recoveries to 28,77,557 and the active cases to 1,04,105.

July 06, 2021 / 20:18 IST
Story continues below Advertisement
Kerala Chief Minister Pinarayi Vijayan

With Kerala logging 14,373 fresh COVID-19 cases on Tuesday, pushing the caseload to 29,96,094, the state government decided to give preference to college students aged between 18-23 years, private bus employees and migrant workers in the vaccination drive.

As many as 10,751 persons have been cured of the infection, taking the total recoveries to 28,77,557 and the active cases to 1,04,105, the government said in a press release. The toll mounted to 13,960 with the addition of 142 recent deaths due to the infection. In the last 24 hours ending 2pm, 1,31,820 samples were tested and the Test Positivity Rate (TPR) was 10.9 per cent. So far, 2,37,68,112 samples have been tested. There are 88 areas where the TPR was over 18 per cent.

Story continues below Advertisement

Karnataka govt exempts travellers from Kerala with at least 1 COVID vaccine dose from producing RT-PCR negative report

A high-level meeting chaired by Chief Minister Pinarayi Vijayan on Tuesday decided to revise the covid curbs after reclassifying areas as per the TPR. Areas where the TPR was below 5 per cent, will come under 'A' category, between 5-10 per cent under 'B' category and 10-15 per cent under 'C' and those with TPR over 15 per cent in the 'D' category.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show